David Heaf

666 total citations
11 papers, 488 citations indexed

About

David Heaf is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, David Heaf has authored 11 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in David Heaf's work include Cystic Fibrosis Research Advances (3 papers), Asthma and respiratory diseases (3 papers) and Antibiotic Resistance in Bacteria (2 papers). David Heaf is often cited by papers focused on Cystic Fibrosis Research Advances (3 papers), Asthma and respiratory diseases (3 papers) and Antibiotic Resistance in Bacteria (2 papers). David Heaf collaborates with scholars based in United Kingdom and United States. David Heaf's co-authors include John R. W. Govan, C. Anthony Hart, Rosalind L Smyth, Katharine Cheng, Catherine Doherty, Craig Winstanley, Hendrik van Saene, Jack Price, P Weller and Peter C. Hindmarsh and has published in prestigious journals such as The Lancet, The Journal of Pediatrics and Pediatric Research.

In The Last Decade

David Heaf

11 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Heaf United Kingdom 7 352 165 157 78 54 11 488
Jill M. Van Dalfsen United States 7 691 2.0× 160 1.0× 85 0.5× 73 0.9× 129 2.4× 8 819
T. Pressler Denmark 13 406 1.2× 179 1.1× 86 0.5× 28 0.4× 76 1.4× 28 614
Adelaida Lamas Spain 11 260 0.7× 178 1.1× 64 0.4× 31 0.4× 100 1.9× 24 539
Simon C Langton Hewer United Kingdom 10 389 1.1× 122 0.7× 82 0.5× 34 0.4× 101 1.9× 23 531
G. Döering Germany 8 490 1.4× 266 1.6× 83 0.5× 20 0.3× 169 3.1× 14 630
Anita Laxova United States 5 660 1.9× 109 0.7× 60 0.4× 25 0.3× 103 1.9× 5 733
J. Maddison United Kingdom 7 429 1.2× 128 0.8× 97 0.6× 14 0.2× 96 1.8× 10 562
B. Przyklenk Germany 8 280 0.8× 112 0.7× 60 0.4× 23 0.3× 112 2.1× 18 396
R.W. Brimicombe Netherlands 11 248 0.7× 78 0.5× 101 0.6× 25 0.3× 113 2.1× 13 393
Luiz Vicente F. da Silva Filho Brazil 9 215 0.6× 81 0.5× 38 0.2× 14 0.2× 171 3.2× 18 372

Countries citing papers authored by David Heaf

Since Specialization
Citations

This map shows the geographic impact of David Heaf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Heaf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Heaf more than expected).

Fields of papers citing papers by David Heaf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Heaf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Heaf. The network helps show where David Heaf may publish in the future.

Co-authorship network of co-authors of David Heaf

This figure shows the co-authorship network connecting the top 25 collaborators of David Heaf. A scholar is included among the top collaborators of David Heaf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Heaf. David Heaf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Heaf, David, et al.. (2016). Une ruche respectueuse des abeilles : la ruche Warré / David Heaf. 1 indexed citations
2.
Baillie, Colin, et al.. (2015). An integrated care pathway for optimizing the investigation and management of pediatric pleural empyema. Journal of Pediatric Infectious Diseases. 2(2). 77–82. 2 indexed citations
3.
Denton, Miles, et al.. (2008). The UK Cystic Fibrosis Trust Infection Control Working Group. 6 indexed citations
4.
Heaf, David & J Wirz. (2001). The Intrinsic Value and Integrity of Plants in the Context of Genetic Engineering Proceedings of an Ifgene Workshop on 9-11 May 2001 at the Goetheanum, Dornach, Switzerland. 3 indexed citations
5.
Price, Jack, et al.. (1997). Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatric Pulmonology. 24(3). 178–186. 6 indexed citations
6.
Price, Jack, et al.. (1997). Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatric Pulmonology. 24(3). 178–186. 62 indexed citations
7.
Cheng, Katharine, Rosalind L Smyth, John R. W. Govan, et al.. (1996). Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. The Lancet. 348(9028). 639–642. 319 indexed citations
8.
Corkill, John E., et al.. (1994). Effect of pH and CO2 on In Vitro Susceptibility of Pseudomonas cepacia to β-Lactams. Pediatric Research. 35(3). 299–302. 7 indexed citations
9.
Seddon, Paul, et al.. (1992). Branhamella catarrhalis colonization in preschool asthmatics. Pediatric Pulmonology. 13(3). 133–135. 10 indexed citations
10.
Macfarlane, P I & David Heaf. (1990). Changes in airflow obstruction and oxygen saturation in response to exercise and bronchodilators in cystic fibrosis. Pediatric Pulmonology. 8(1). 4–11. 20 indexed citations
11.
Heaf, David, Jaques Belik, Alan R. Spitzer, Michael H. Gewitz, & William W. Fox. (1982). Changes in pulmonary function during the diuretic phase of respiratory distress syndrome. The Journal of Pediatrics. 101(1). 103–107. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026